This app is for sale. Asking price: $21,668
3.1x revenue
348 buyers have viewed this
3 inquiries sent
Shotwise app icon

Shotwise

Wegovy, Ozempic, Mounjaro

Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.

Worldwide Release Date: January 9, 2025

Verified withRevenueCatFor Sale
#214 MRR
#355 Revenue
#72 in Health & Fitness
Transparency: 10/10

Star Ratings(148 ratings | avg ★ 4.7)

App Store (148 ratings)

us

4.8

122 ratings

gb

4.3

15 ratings

ca

5.0

6 ratings

nl

2.5

2 ratings

de

3.0

1 rating

fr

5.0

1 rating

br

5.0

1 rating

Downloads (28 days · iOS + Android)

86

Total Downloads (Play Store)

100+

Last 28 days

Revenue

$583

AR

$7,001

MRR

$1,083

ARR

$13,001

Cash Flow Index

0.5x

Active Subscriptions

715

ARPAS

$0.82

Active Customers

537

New Customers

86

Subscription Penetration

133.1%

ARPU

$1.09

RPD

$1.09

ARPPU

$1.52

LTV

$15

MRR Growth (28d)

-4.8%

Subscriber Growth (28d)

-3.2%

All data is verified through RevenueCat. Last updated: Sep 16, 2026, 09:45:07 PM UTC.

App Screenshots

Shotwise screenshot 1
Shotwise screenshot 2
Shotwise screenshot 3
Shotwise screenshot 4
Shotwise screenshot 5

In-App Pricing

ShotWise Pro Annual$24.99
ShotWise Pro Annual$9.99
Shotwise Pro Annual$4.99

Tech Stack

Frontend
ExpoExpo

About This Listing

A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.

Asking Price

$21,668

Sale Details

Business Operations Started

Jan 2025

Assets Included in Sale

Social media accounts

Source Code Included

Yes

Post-Sales Support

Yes, seller will provide support
Privacy Policy|Terms of Service